MYRIAD GENETICS - Dusseldorf Stock Exchang
MYRIAD GENETICS - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
MYRIAD GENETICS - Dusseldorf Stock Exchang (MYD) - Total Liabilities
Latest total liabilities as of June 2024: €344.60 Million EUR
Based on the latest financial reports, MYRIAD GENETICS - Dusseldorf Stock Exchang (MYD) has total liabilities worth €344.60 Million EUR as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MYRIAD GENETICS - Dusseldorf Stock Exchang - Total Liabilities Trend (2016–2024)
This chart illustrates how MYRIAD GENETICS - Dusseldorf Stock Exchang's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MYRIAD GENETICS - Dusseldorf Stock Exchang Competitors by Total Liabilities
The table below lists competitors of MYRIAD GENETICS - Dusseldorf Stock Exchang ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
VALNEVA (AYJ.SG)
STU:AYJ
|
Germany | €300.29 Million |
|
Solid Impact Investments Corp.
V:SOLI-P
|
Canada | CA$6.67K |
|
TOC CO LTD (T3O.SG)
STU:T3O
|
Germany | €15.73 Billion |
|
KHD HUM WED IND N
MU:HETA
|
Germany | €142.98K |
Liability Composition Analysis (2016–2024)
This chart breaks down MYRIAD GENETICS - Dusseldorf Stock Exchang's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MYRIAD GENETICS - Dusseldorf Stock Exchang's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MYRIAD GENETICS - Dusseldorf Stock Exchang (2016–2024)
The table below shows the annual total liabilities of MYRIAD GENETICS - Dusseldorf Stock Exchang from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | €363.30 Million | +16.11% |
| 2023-06-30 | €312.90 Million | -11.33% |
| 2022-06-30 | €352.90 Million | -27.45% |
| 2020-06-30 | €486.40 Million | +2.66% |
| 2019-06-30 | €473.80 Million | +126.48% |
| 2018-06-30 | €209.20 Million | -53.16% |
| 2017-06-30 | €446.60 Million | +237.31% |
| 2016-06-30 | €132.40 Million | -- |